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ScienceDirectThe majority of the C-type lectin-like domains in the human
genome likely to bind sugars have been investigated
structurally, although novel mechanisms of sugar binding are
still being discovered. In the immune system, adhesion and
endocytic receptors that bind endogenous mammalian glycans
are often conserved, while pathogen-binding C-type lectins on
cells of the innate immune system are more divergent. Lack of
orthology between some human and mouse receptors, as well
as overlapping specificities of many receptors and formation of
receptor hetero-oligomers, can make it difficult to define the
roles of individual receptors. There is good evidence that
C-type lectins initiate signalling pathways in several different
ways, but this function remains the least well understood from a
mechanistic perspective.
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Introduction
Complex oligosaccharides on cell surfaces and glyco-
proteins in blood and other biological fluids often serve
as recognition signals that are bound by specific glycan-
binding receptors known as lectins [1]. The C-type
lectins are the largest and most diverse of the lectin
families found in animals. C-type lectins contain an
independently folding, modular carbohydrate-recogni-
tion domain (CRD) that in most cases binds sugars by
ligation to Ca2+, making the sugar-binding activity
Ca2+-dependent [2]. Many receptors containing C-type
CRDs are found in the immune system, with functions
including cell adhesion, glycoprotein turnover or path-
ogen recognition based either on recognition of endog-
enous mammalian glycans or on binding to glycans on
micro-organisms.Current Opinion in Structural Biology 2015, 34:26–34 The ways that some C-type lectins function in the im-
mune system have been well established. For example,
the importance of the selectins in interactions between
leukocytes and endothelia is fully supported by pheno-
types of knock-out mice and symptoms of a human
congenital disorder of glycosylation that prevents synthe-
sis of the fucosylated ligands recognized by the selectins
[3,4]. Similarly, mannose-binding protein deficiency in
humans shows that antibody-independent fixation of
complement triggered by binding of serum mannose-
binding protein to sugars on the surface of pathogens is
an essential part of the innate immune response in young
infants [5].
This review considers recent advances in our understand-
ing of how C-type lectins in the immune system work,
with an emphasis on summarizing the currently available
structural information and defining the areas where func-
tional and mechanistic information is still outstanding.
Structures of C-type lectins: the current
position
Structural analysis of the prototype C-type CRD from
serum mannose-binding protein showed that residues
conserved between C-type CRDs form a hydrophobic
core and disulfide bonds that define the overall fold of the
domain [6]. Additional conserved residues ligate a Ca2+
that forms the basis of a primary sugar-binding site. Many
protein domains that have the C-type CRD fold lack the
conserved Ca2+-binding site and thus do not bind sugars,
which has led to the distinction between the sugar-
binding C-type CRDs and the broader family of C-type
lectin-like domains (CTLDs) [2]. About half of the
CTLDs contain residues required for binding of the
conserved Ca2+, and for the human proteins, Ca2+-de-
pendent sugar binding has now been demonstrated for
most of the domains that contain these residues. Crystal
structures are available for the majority of these proteins,
although not all are with bound glycan ligands (Figure 1).
The CRDs that bind sugars through the canonical Ca2+-
ligation mechanism fall in five of the structural groups
defined by sequence similarity within the domain and
the positions of the CRD in relationship to other protein
domains (Genomics Resource for Animal Lectins;
URL: http://www.imperial.ac.uk/research/animallectins).
Structural information is available for members of each
of these groups. Binding of sugars to two proteins that lack
the canonical sugar-binding site, dectin-1 and layilin, sug-
gests the presence of non-canonical sugar-binding sites in
these proteins (Figure 1).www.sciencedirect.com
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Summary of current state of structural analysis of glycan-binding C-type CRDs. Dendrogram at the left shows the relationships of the sequences
of human CRDs, with the domains that bind glycans at the conserved Ca2+ site in yellow boxes and the domains that appear to bind glycans
through non-canonical sites in blue boxes. Members of other groups that contain C-type lectin-like domains but lack key residues usually
associated with Ca2+ and sugar-binding are not shown individually. Names of proteins containing the full set of residues needed to form canonical
sugar-binding sites are shown in green when structures with bound glycan ligands have been obtained, in red for those cases in which unliganded
structures have been determined and in black where structures have not been elucidated. The organization of proteins containing these CRDs is
depicted schematically at the right, with the positions of CRDs, shown as green spheres, shown in relationship to other domains. Groups 2, 4 and
6 are receptors with transmembrane sequences. Proteins that bind sugars but lack the canonical binding site are indicated in blue. The crystal
structure of dectin-1 has been determined and a possible mode of sugar binding has been suggested [63].In all C-type CRD–glycan complexes examined so far,
the presence of the principal Ca2+ results in ligation of a
monosaccharide through two vicinal hydroxyl groups as
originally seen for serum mannose-binding protein. In-
vestigation of the full complement of human C-type
lectins has largely borne out the early finding that the
specificity for mannose-type sugars, which contain adja-
cent equatorial 3-hydroxyl and 4-hydroxyl groups (man-
nose, GlcNAc, and glucose) is determined by the
presence of the residues EPN in the primary Ca2+ site
while binding of galactose-type sugars in which the 4-
hydroxyl group is axial (galactose and GalNAc) have QPD
[7]. However, there have been some surprises. For exam-
ple, the EPN-containing CRD of langerin, a pathogen-
binding C-type lectin on Langerhans cells, binds man-
nose-type sugars at the primary-binding site but can also
accommodate sulphated galactose at this site with the
non-optimal Ca2+ ligation of galactose compensated bywww.sciencedirect.com charge–charge interactions between the sulphate group
and two lysine residues [8]. The ability of blood den-
dritic cell antigen 2 (BDCA-2) to bind galactose-termi-
nated glycans in spite of the fact that it contains an
EPN motif has recently been explained by demonstra-
tion that the mannose residue in terminal Galb1–
4GlcNAcb1–2Man structures is in the primary binding
site while galactose occupies an adjacent secondary site,
making it somewhat analogous to mouse dendritic cell
immunoreceptor 2 (DCIR2) [9,10]. Finally, NMR
analysis of ligand binding to DC-SIGN, a dendritic cell
receptor that binds both high mannose oligosaccharides
on viruses and Lewisx-containing glycans, suggests that
in some cases crystallography may reveal only one of
multiple modes of ligand binding [11,12]. Multiple
orientations of GalNAc-containing ligands bound to
the macrophage galactose lectin have also been
detected [13].Current Opinion in Structural Biology 2015, 34:26–34
28 Carbohydrate–protein interactions and glycosylationIn addition to the primary binding site, screening of
glycan arrays and structural analysis of C-type CRDs in
complex with glycan ligands has increasingly demonstrat-
ed the importance of contacts outside of the primary
sugar-binding site in extended or secondary binding sites
[14]. Examples include binding of high mannose oligo-
saccharides to DC-SIGN, binding of Lewisx-containing
ligands to the scavenger receptor C-type lectin and the
selectins, and binding of glycolipids such as trehalose
dimycolate to the macrophage receptor mincle [15]. In
addition to the examples described in the previous
reviews [14,15], extended site mechanisms for binding
biantennary N-linked glycans have recently been dem-
onstrated for the mouse dendritic cell immunoreceptor 2
(DCIR2) (Figure 2a) and BDCA-2 [9,10].
At another extreme, a proposed binding interaction of
sialylated glycans on IgG with SIGNR1, one of the mouse
homologs of human DC-SIGN, is quite minimal: in the
crystals, just the carboxyl group of the sialic acid interacts
with the protein by making coordination bonds to the
bound Ca2+ (Figure 2b) [16]. However, a role for glycan
recognition in binding of IgG to DC-SIGN has been
difficult to document [17]. While it may be that
this controversy reflects difference between humanFigure 2
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Current Opinion in Structural Biology 2015, 34:26–34 DC-SIGN and mouse SIGNR1, it is also interesting to
note that the position and ligation of Ca2+ in the crystals of
mouse SIGNR1, obtained in the presence of high sul-
phate and low Ca2+, differs from that observed in most
other CRD-sugar complexes and no adjacent second Ca2+
near the sugar-binding site is observed. This latter obser-
vation may be significant, because the four amino acid
side chains that form this second Ca2+ site in human DC-
SIGN and many other C-type CRDs are all present in
SIGNR1 (Figure 2c). If the CRD in the structure of
mouse SIGNR1 is not fully ligated with Ca2+, the con-
formation in the crystal may not reflect the organization of
the binding site under physiological conditions. At low
Ca2+ concentration, crystals of the CRD from human and
mouse mincle, a macrophage receptor that binds glyco-
conjugates on the surface of mycobacteria and fungi,
similarly lack the second Ca2+, resulting in a re-arrange-
ment of the primary Ca2+ site [18,19,20]. However,
bound sugar ligand is only observed under conditions
of higher Ca2+, when the second Ca2+ is occupied and the
primary site takes on its canonical geometry.
In proteins such as mouse DCIR2 and BDCA-2, which
lack the accessory Ca2+, residues that would have ligated
this Ca2+ are changed so that a basic amino acid side chainCurrent Opinion in Structural Biology
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binding to CRDs with a single Ca2+ site shows first order
dependence on Ca2+ concentration, while CRDs with
multiple Ca2+ sites have second or third-order depen-
dence [9,20]. The presence of additional sites also
shifts the midpoint of the transition between sugar-bind-
ing and inactive conformations. The precise dependence
on Ca2+ may be important in determining how sensitive
CRDs are to variation in the Ca2+ concentration in various
intracellular compartments, such as the endoplasmic re-
ticulum, Golgi, and endosomes as well as regions of the
extracellular matrix. In some cases, a sharp transition
between active and inactive conformations, resulting
from the higher order Ca2+ dependence, may be impor-
tant for their biological functions, for example in ligand
release from endocytic receptors in endosomes.
Knowledge of the mechanism of carbohydrate-recogni-
tion by C-type CRDs is now sufficient that glycomimetic
drugs can be envisaged [21]. Mimics of sialyl-Lewisx that
inhibit binding of all three selectins have been developed
through a fragment-based screening approach [22]. One
of these is now in clinical trials for sickle cell disease,
where selectin-mediated interactions of leukocytes and
platelets with vascular endothelium contribute to vas-
culo-occlusive crisis [23].
Relationships of C-type lectins across species
Comparison of C-type lectins in the immune systems of
humans and mice shows that there are several distinctFigure 3
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for many receptors that bind endogenous glycans and
function in adhesion and glycoprotein clearance by en-
docytosis. Examples of proteins for which it is possible to
identify well-defined one-to-one orthologs between spe-
cies include the selectin cell adhesion molecules [24] as
well as the mannose receptor and the scavenger receptor
C-type lectin, which function in clearance of serum
glycoproteins released at sites of infection or inflamma-
tion [25,26].
In contrast, many receptors that bind to pathogen glycans
have undergone recent dramatic evolutionary changes,
resulting in the absence of simple orthology between
mice and humans. The differences include absence of
specific proteins in one of the species and very recent
duplications and divergences. For example, the human
genome encodes two closely related proteins DC-SIGN
and DC-SIGNR (L-SIGN) while there are eight genes for
mouse SIGN proteins, none of which is organized in the
same way as DC-SIGN and DC-SIGNR with extended
neck domains between the CRD and the membrane
[27,28]. Similarly, in the collectin family, mice express
two different forms of mannose-binding protein, while
there is only one functional gene in humans [29]. It
appears that there has been significant evolutionary pres-
sure on some of these receptors during the recent evo-
lution of mammals, possibly reflecting the fact that these
receptors are targets for viruses that may have selected for
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main organizations were established early. However, recent evolution
een mammals such as humans and mice.
Current Opinion in Structural Biology 2015, 34:26–34
30 Carbohydrate–protein interactions and glycosylationabsolute rule that only receptors that bind endogenous
ligands are conserved, since langerin and mincle both
bind pathogen glycans but their properties are very simi-
lar across mammalian species [30,31].
The absence of orthology between mice and humans
for some proteins puts restrictions on the use of mouse
models in understanding the functions of C-type lec-
tins. In some cases, such as for the selectins and the
mannose receptor, mice in which a particular gene is
knocked out will provide information about the func-
tion of a well-defined human orthologue, while in other
cases, including DC-SIGN and the mouse SIGNs, care
must be taken to select an appropriate mouse model
[28].
Functions of C-type lectins in signalling
Many C-type lectins found on cells in the immune system
have been reported to initiate intracellular signalling, but
this remains the least well understood function of these
receptors. The different arrangements of these receptors
in the plasma membrane reflects the fact that there are
several distinct mechanisms by which sugar binding at theFigure 4
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Current Opinion in Structural Biology 2015, 34:26–34 cell surface leads to events on the cytoplasmic side of the
membrane (Figure 4).
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lar domains involved in signalling. Sequence motifs in the cytoplasmic
sine residues become phosphorylated, making them targets for
www.sciencedirect.com
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events involve the CARD9/MALT1/Bcl-10 adapter com-
plex. The consequences of ligand binding to prolectin are
less well understood. In this instance, the cytoplasmic
domain interacts with Grb2, an adapter protein that often
recruits additional signalling molecules [34], but such
binding partners have not yet been reported The pres-
ence of signalling motifs in the cytoplasmic domain of
these sugar-binding receptors is reminiscent of the ar-
rangement of another group of glycan-binding receptors,
the siglecs [35].
Several other C-type lectins of myeloid cells, including
mincle, dectin-2 and BDCA-2, lack intrinsic signalling
domains but activate Syk through association with the
common Fc receptor g chain (FcRg), which contains an
ITAM. Signalling through association of FcRg with min-
cle and dectin-2 occurs via activation of the CARD9/
MALT1/Bcl-10 adapter complex by Syk, promoting out-
comes that include secretion of cytokines TNF-a and IL-
6 [36–38]. Antibodies to BDCA-2, which is a receptor of
plasmacytoid dendritic cells, initiate signalling through
the FcRg chain, but in this case the result is suppression
of inflammatory cytokines through a pathway involving
BTK kinase, BLNK adapter protein and phospholipase
Cg2 [39]. BDCA-2 is found in primates and some more
distantly related species, but the gene is not present in
mice. The molecular mechanisms for stimulation of Syk,
either directly by dectin-1 or indirectly through FcRg,
have not been determined. Clustering or crosslinking of
receptors by ligand binding is likely to be important, but
so far there is little information about the oligomeric state
of mincle, dectin-2 or BDCA-2 or the stoichiometry of the
complexes that form with FcRg.
DC-SIGN and the macrophage galactose receptor
(MGL) are both reported to modulate signalling path-
ways activated by toll-like receptors. It is proposed that
the adapter LSP1 interacts with the cytoplasmic domain
of DC-SIGN and becomes phosphorylated through a
pathway initiated by toll-like receptor 4 [40]. Previous
work showed that mannose-containing ligands, such as
those found on Mycobacterium tuberculosis, lead to assem-
bly of adapter proteins KSR1 and CNK and kinase Raf-1,
enhancing proinflammatory cytokine production. Recent
work now demonstrates that fucose-containing ligands,
such as those present on Helicobacter pylori, result in
binding of a different set of proteins, IKKe kinase and
the deubiquitinating enzyme CYLD, leading to nuclear
accumulation of kinase Bcl3 and suppression of the
proinflammatory response [41]. From a mechanistic point
of view, the basis for differential activation of DC-SIGN
by different glycan ligands is difficult to understand,
since structures of the unliganded CRD and the CRD
bound to both mannose-containing and fucose-contain-
ing ligands, obtained both by crystallography [42,43] and
more recently by NMR [11,12], do not indicate that therewww.sciencedirect.com are changes in the protein structure upon binding of any
of the ligands. In spite of evidence for activation of
various downstream pathways by ligands for MGL, no
specific binding partners have been proposed for MGL
and less is known about the details of ligand binding [44].
The situation with these receptors may become clearer
when the nature of the interaction between DC-SIGN
and LSP1 has been defined. Both DC-SIGN and MGL
mediate endocytosis [43,45,46] and have cytoplasmic
domains containing YXXF motifs associated with traf-
ficking through the clathrin-mediated endocytic pathway
[47]. However, both receptors are pre-formed oligomers
[48,49] and in the case of DC-SIGN, the YXXL sequence
resembles a hemi-ITAM, but does not function in this
way [50].
The importance of hetero-oligomers and
spatial arrangements of CRDs
Binding of pathogen glycans by several C-type lectins,
including DC-SIGN, MGL, serum mannose-binding pro-
tein and langerin is dependent on formation of homo-
oligomers. Potential formation of hetero-oligomers cre-
ates an additional level of complexity when assessing the
functions of C-type lectins in immunity against patho-
gens.
Recent evidence suggests that functions of both mincle
and dectin-2 on macrophages are dependent on the
macrophage protein MCL, a C-type lectin-like protein
also known as dectin-3. The importance of mincle in
recognition of the glycolipid trehalose dimycolate, a major
virulence factor of mycobacteria and a potent stimulator
of inflammatory responses, is indicated by complete
abrogation of inflammatory response to trehalose dimy-
colate in macrophages deficient in mincle as well as in
mincle knockout mice [51,52]. However, MCL has also
been shown to initiate signalling following stimulation
with trehalose dimycolate [53]. Formation of a func-
tional complex of mincle with MCL and FcRg has been
suggested, based on co-immunoprecipitation of mincle
and MCL when they are both expressed in 293T cells
[54]. But analysis of MCL-knockout mice suggests that
MCL is required to up-regulate expression of mincle in
response to stimulation with trehalose dimycolate and no
evidence for hetero-oligomer formation was seen when
MCL and mincle were co-expressed in the mouse mac-
rophage-like RAW-264.7 cells [55]. These findings sup-
port the alternative interpretation that initial sensing of
trehalose dimycolate by constitutively expressed MCL
stimulates signalling through activation of the CARD9/
MALT1/Bcl-10 complex leading to activation of the
transcription factor NFkB, which in turn up-regulates
transcription of mincle mRNA. Binding of trehalose
dimycolate to MCL has been described [19,53]. How-
ever, the C-type lectin-like domain of MCL does not
contain the conserved residues needed for Ca2+-depen-
dent sugar-binding of the trehalose moiety of trehaloseCurrent Opinion in Structural Biology 2015, 34:26–34
32 Carbohydrate–protein interactions and glycosylationdimycolate, or residues that form a hydrophobic groove
seen in the mincle CRD that are predicted to accommo-
date the acyl chains of a glycolipid [18], so the mechanism
of trehalose dimycolate binding to MCL is not clear.
The mannose-specific C-type lectin dectin-2 binds
pathogens including mycobacteria and fungi such as
Candida and Malassezia, which also interact with mincle
but through different ligands: dectin-2 binds the capping
mannose residues of lipoarabinomannan from mycobac-
teria or terminal mannose residues on fungal mannans
[56,57,58]. Candida mannan also binds weakly to MCL
and MCL-knockout mice are more susceptible to Candida
infection than wild type mice, suggesting a role for MCL
in anti-fungal immunity, possibly through formation of a
hetero-oligomer with dectin-2 [58]. Dectin-2 has been
seen to co-immunoprecipitate with MCL both in trans-
fected RAW 264.7 cells and in mouse bone-marrow
derived macrophages. In addition, bimolecular fluores-
cence complementation assays indicate formation of het-
ero-dimers between dectin-2 and MCL at the cell surface,
although homo-dimers of dectin-2 and MCL also form
[58]. The relative importance of hetero-oligomers versus
homo-oligomers and the exact nature of the interactions
between the different receptors remain to be determined.
Structural analysis of oligomeric C-type lectins has shown
the importance of the spatial arrangement of C-type
CRDs in determining specificity for pathogen glycans.
In one model, exemplified by serum mannose-binding
protein, CRDs with low affinity and broad specificity are
held in fixed geometrical arrangements in order to bind
arrays of terminal sugars on bacterial and fungal cell
surfaces [2]. In an alternative model, based on DC-SIGN,
CRDs that bind restricted oligosaccharide motifs are
flexibly linked and able to accommodate the disposition
of these glycans on viral surfaces [59]. Results from recent
quantitative imaging studies illustrate that, for cell sur-
face receptors such as DC-SIGN, the arrangement of the
oligomeric receptors on the cell-surface is also important
for internalization of viruses [60]. These methods reveal
that DC-SIGN is clustered in microdomains on the
plasma membranes of dendritic cells and on transfected
cell lines and that each microdomain contains only 1–2
copies of the DC-SIGN tetramer. Internalization and
infection studies with dengue virus, a small virus that
binds to DC-SIGN, in cells transfected with DC-SIGN
showed that no re-arrangement of micro-domains is re-
quired for efficient internalization of dengue virus and
that the small number of DC-SIGN molecules in each
micro-domain is sufficient to allow productive internali-
zation and infection.
Spatial arrangement of the CRDs in the langerin trimer
has also been studied in the context of formation of
Birbeck granules, the specialized structures of the endo-
somal pathway with which langerin is associated inCurrent Opinion in Structural Biology 2015, 34:26–34 Langerhans cells [61]. Langerin expression is absolutely
required for formation of Birbeck granules, as indicated
by the absence of these structures in the langerin knock-
out mouse and in humans with a very rare mutation in the
langerin gene that prevents langerin expression [62].
Mutation of a residue located at the interface between
adjacent CRDs in the langerin trimer has now been
shown to cause destabilization of the langerin trimer
and this mutation also causes abnormal membrane archi-
tecture in Birbeck granules as well as decreasing the
affinity for HIV gp120 [61].
Conclusions
The broad outlines of the mechanism by which simple
sugars are bound to C-type CRDs, established roughly
twenty years ago, remain valid. However, the ways that
accessory binding sites lead to selectivity for specific
classes of oligosaccharide ligands continue to be elucidat-
ed. While further structures of CRDs with bound ligand
are needed, the current state of structural information
makes it possible to envision that a relatively complete
description of the sugar-recognition aspect of C-type
lectin function can be achieved. The mechanisms by
which these lectins participate in cell adhesion and in
glycoprotein clearance are also now relatively well under-
stood. In contrast, roles of C-type lectins in signalling are
continuing to emerge and description of the mechanisms
by which glycan binding leads to initiation of signalling
pathways remains an area of active investigation.
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